Learn new strategies for your research as you engage with the world's most successful innovators at the 2015 R&D 100 Awards & Technology Conference. Elevate your level of knowledge, expertise, and increase your productivity and successful outcomes.

Sarah Schoen, a wildlife biologist for the U.S. Geological Survey, and Rob Kaler, a biologist for the U.S. Fish and Wildlife Service, on Friday performed necropsies on common murres, part of an effort by dozens of scientists to explain the massive die-off of common murres that began one year ago.

Nearly half of California adults, including one out of every three young adults, have either prediabetes - a precursor to type 2 diabetes - or undiagnosed diabetes, according to a study.

What Makes Your Laboratory Unique? Your people, your protocols, the work you do to change the world - and the instruments and equipment that help you to reach your goals. You shouldn't have to fit your workflows around standard equipment. Your Equipment should be adaptable to you, while operating within the safety, performance, and compliance parameters that your work requires. In short, your laboratory equipment should work the way you do.

Liposomes are currently used as drug delivery vehicles but recognized by the immune system. Scientists from the universities of Basel and Fribourg have shown that special artificial liposomes do not elicit any reaction in human and porcine sera as well as pigs.

With the requirement to increase testing of agricultural and food products for the presence of aflatoxins, reliable and convenient testing methods that utilize readily available standard laboratory tools are in demand. For the general laboratory, newer technologies for aflatoxin analysis may be financially unattainable. This app note focuses on the innovative method developed to accurately test aflatoxins using general equipment.

Researchers have taken some initial steps toward the creation of bioengineered human hearts using donor hearts stripped of components that would generate an immune response and cardiac muscle cells generated from induced pluripotent stem cells (iPSCs), which could come from a potential recipient.

The Food and Drug Administration expanded approval of a Pfizer drug to treat a small subset of lung cancer patients with a rare mutation.